Tibet Rhodiola Pharmaceutical Holding Co.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "723.50",
          "val2": "892.30",
          "chgp": "-18.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "213.20",
          "val2": "240.80",
          "chgp": "-11.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.10",
          "val2": "10.40",
          "chgp": "-2.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.10",
          "val2": "2.10",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "282.80",
          "val2": "191.10",
          "chgp": "47.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "294.70%",
          "val2": "246.50%",
          "chgp": "4.82%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.28% vs -10.52% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -13.25% vs 30.47% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,950.60",
          "val2": "2,776.30",
          "chgp": "6.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,003.40",
          "val2": "967.90",
          "chgp": "3.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.80",
          "val2": "9.60",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.50",
          "val2": "-18.80",
          "chgp": "81.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "917.00",
          "val2": "1,057.10",
          "chgp": "-13.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "313.40%",
          "val2": "321.90%",
          "chgp": "-0.85%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

723.50

892.30

-18.92%

Operating Profit (PBDIT) excl Other Income

213.20

240.80

-11.46%

Interest

10.10

10.40

-2.88%

Exceptional Items

-2.10

2.10

-200.00%

Consolidate Net Profit

282.80

191.10

47.99%

Operating Profit Margin (Excl OI)

294.70%

246.50%

4.82%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -18.92% vs 103.44% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 47.99% vs 23.21% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,950.60

2,776.30

6.28%

Operating Profit (PBDIT) excl Other Income

1,003.40

967.90

3.67%

Interest

12.80

9.60

33.33%

Exceptional Items

-3.50

-18.80

81.38%

Consolidate Net Profit

917.00

1,057.10

-13.25%

Operating Profit Margin (Excl OI)

313.40%

321.90%

-0.85%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 6.28% vs -10.52% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -13.25% vs 30.47% in Dec 2024

All Annual Results